At the 2026 JP Morgan Healthcare Conference, one message stood out: AI has moved from experimental to essential. 🚀

#AIinHealthcare #Biopharma #LifeSciences #HealthcareInnovation #JPM2026 #AIStrategy #RDInnovation #FutureofHealthcare #AltumInsights #AltumWave

AI at JP Morgan Healthcare Conference 2026: From Disruption to Deployment - Altum How AI Is Becoming Foundational to Biopharma Strategy, R&D, and Risk Management The 2026 JP Morgan Healthcare Conference made one theme unmistakably clear: AI has moved from experimental to existential for healthcare and life sciences organizations. Across pharma, biotech, health systems, and technology companies, leaders emphasized that AI is no longer a peripheral innovation—it is quickly becoming core infrastructure for competitive advantage, operational resilience, and scientific discovery. While generative AI commanded attention in 2024 and 2025, this year’s conversations demonstrated a deeper shift: organizations are now building enterprise-wide systems, partnerships, and capital investments that position AI as a long-term strategic capability rather than a near-term pilot. Below, Altum distills the most important developments from JPM and outlines what leaders should take away as AI becomes a defining force in biopharma strategy. AI Becomes Foundational Infrastructure—Not a Side Experiment A defining moment of the conference was the announcement of a $1 billion co-innovation AI lab between NVIDIA and Eli Lilly, designed to accelerate lab automation, drug discovery, and clinical development. This is one of the largest AI‑in‑pharma investments to date and signals three important shifts: AI is moving upstream. Drug discovery, molecular design, and early research are now priority AI use […]

AI isn’t experimental anymore — it’s essential. 🚀

altumstrategy.com/portfolio-it...

#AI #HealthcareInnovation #LifeSciences #Biopharma #DigitalTransformation #JPM2026 #FutureOfHealth #AltumWave #AltumStrategyGroup

J.P. Morgan 2026: How MedTech Leaders Are De-Risking Product Development | eg technology Understand the intricacies of MedTech product development risk highlighted at the J.P. Morgan Healthcare Conference.

What’s shaping MedTech product development in 2026? At #JPM2026, one theme stood out: growth now depends on how effectively teams de‑risk development. From smarter AI integration to stronger execution and investor focus, we break down the key takeaways: buff.ly/XIAUi0i

For those of us who left #JPM2026 thinking that all the problems in female health have been solved except the money problem, take note.

The money (or lake of) is a problem bc the underlying issues are not resolved. This isn’t “admiring the problem” this is naming it and rooting it out. TY Lagos!

Another successful JPM is in the books 📕

From announcing a clinical trial for Scribe's lead cardiometabolic asset STX-1150, to speaking at events like Fierce JPM Week, check out our #JPM2026 in photos and links below.

Reflections from JPM: a turning point for platform companies like Lunai Bioworks

From JPM 2026, one takeaway is clear: urgency in biopharma partnering is rising fast, and our BioSymetrics team felt it across conversations and meetings. #TechBio #JPM2026 #DrugDiscovery

The CoSyne team had a fantastic time at the JP Morgan Healthcare conference in San Francisco last week!

#JPM2026 #CoSyneTherapeutics #BioTech #RareDisease #GBM

Key takeaway from #JPM2026: Neurology is now a strategic growth priority for health systems.
The focus is on:
• Expanding neuroscience programs
• AI-enabled imaging to cut time-to-diagnosis (stroke/TIA)
• Precision diagnostics & biomarkers
• Deeper pharma/biotech partnerships

@ucberkeleyofficial.bsky.social’s life sciences ecosystem lit up #JPM2026 at the Berkeley Bio Startup Showcase, where biotech startups connected with investors and industry leaders. @mti-ucb.bsky.social is proud to have co-supported this event, hosted by the Life Sciences Entrepreneurship Center ✨

FROM BENCH TO BEDSIDE: Unveiled at #JPM2026, our plans to enter the clinic in mid-2026 underscore Scribe’s mission to shift cardiovascular care for millions of people – from late, symptom-driven intervention to earlier, durable risk reduction grounded in human genetics.

🩺 Alors que le sommet mondial de la santé #JPM2026 se tient actuellement, un audit complet des 100 essais cliniques les plus avancés sur les syndromes post-infectieux (#PAIS) met en lumière un tournant important pour la recherche.

✨We participated in panels across the city, including #JPM2026 and hosted visits with Performers, meetings with potential Program Managers and other engaging opportunities with the best & brightest in biotech

We made our time on the west coast count. Thanks to everyone we met & mingled with! (2/2)

We had a great week connecting with investors and the broader biotech community at #JPM2026.

Thank you to everyone who took the time to meet with our team. We appreciated the opportunity to share our recent progress and what’s on the horizon for 2026!

What a whirlwind at #JPM2026! Grateful for the inspiring chats, new ideas, and connections that make this field so exciting. From BARI in SF: thanks for coming, safe travels home, and let’s keep pushing geroscience forward together! #agingresearch

GSK's Tony Wood sitting on a panel at the JP Morgan Healthcare Conference.

Five panellists, including GSK's Chris Sheldon, are seated on a stage at the JP Morgan Healthcare Conference, facing an audience whose backs are visible.

A classic green and red San Francisco cable car is stopped on tracks on a city street. Tall trees line the street with buildings are visible in the background.

GSK's Kaivan Khavandi sitting on a panel at the JP Morgan Healthcare Conference.

That's a wrap on #JPM2026!

We're leaving inspired and confident in our R&D momentum and the future impact of our pipeline. Our approach, built on cutting-edge innovation and industry-leading partnerships, is driving us to get ahead of disease together.

Check out our highlights ⤵️

#AheadTogether

Biohub, Arc Institute, Tahoe partner on largest perturbation dataset Generation of 120M+ cells and 225,000 perturbation interactions will accelerate virtual cell model development.

We’re partnering with @tahoetherapeutics.bsky.social and
@arcinstitute.org to generate the largest perturbation dataset for virtual cell models. Announced at #JPM2026, the 120M+ cell dataset will be open source to accelerate development of biological foundation models. bit.ly/4pBkZbd

The truth behind the 2026 J.P. Morgan Healthcare Conference 2.8k words, 13 minutes reading time

Leaving #jpm2026, this article hits the nail on the head.

I have been to the main event, but I'm not convinced the conference is real.

www.owlposting.com/p/the-truth-...

Airport sign in San Francisco // Raise capital. // Not tech debt. • MongoDB.

JP Morgan 2026 healthcare conference, summarized.

#JPM2026 Well played, @mongodb.bsky.social

NTI | bio was at #JPM2026 this week with industry leaders to discuss where the healthcare system is most exposed, and how stronger international coordination and preparedness can reduce risk while safeguarding long-term value.

Listen now. ⤵️
jpmorgan.metameetings.net/events/healt...

The termination of $2B in grants by HHS Secretary Kennedy has now been reversed 24 hrs after they were announced during #JPM26 #JPM2026 yesterday. Bulwark confirmed Roll Call's reporting that HHS's decision has now been reversed h/t @samsteindc.bsky.social www.thebulwark.com/p/trump-take... #medsky

ARPA-H announces $50M to expand pediatric care across the country The Advanced Research Projects Agency for Health (ARPA-H) supports transformative research to drive biomedical and health breakthroughs ranging from molecular to societal to provide transformative hea...

We’re raising the standard of care for pediatric cancer patients!

At #JPM2026, we announced $50 million to improve health outcomes for children with complex diseases across the country, beginning with pediatric brain cancer.

Learn about Pediatric Care eXpansion (PCX): arpa-h.gov/news-and-eve...

📢 Coming up at #JPM2026 at 11:15 am PT/2:15 pm ET: Director Alicia Jackson will discuss “Inventing What Comes Next: Make the Impossible Probable for Human Health.” #JPMWeek

🎧 Listen LIVE: jpmorgan.metameetings.net/events/healt...

The future is here, and the release of ChatGPT Health and Claude for Healthcare will be seen as pivotal moments in healthcare.

Thank goodness for @arpa-h.bsky.social. We need more purpose-built AI.

bsky.app/profile/rasu...

#JPM2026

Love the video and great dialogue at #JPM2026.

bsky.app/profile/rasu...

Speaking at the StartupHealth event at JPMorgan conference in San Francisco

Speaking at the StartupHealth event at JPMorgan conference in San Francisco

Vinod Khosla speaks at the StartupHealth event at JPMorgan conference in San Francisco

With Vinod Khosla and colleague at the StartupHealth event at JPMorgan conference in San Francisco

“If superintelligence is the rocket fuel, then I say that purpose-built AI is the guidance system.”

~ Dr @rasushrestha.bsky.social at #JPM2026, StartupHealth

#medsky #pinksocks #digitalhealth

Dr Rasu Shrestha with Esther Dyson at JPMorgan conference.

The world felt calmer for a minute.

So good to reconnect with Esther Dyson, Swiss-born American investor, journalist, author, commentator and philanthropist. She is the executive founder of Wellville, a nonprofit project focused on improving equitable wellbeing.

#JPM2026 #pinksocks #StartupHealth

Speaking on stage at the CancerX event at JPMorgan in San Francisco

Speaking on stage at the CancerX event at JPMorgan in San Francisco

Speaking on stage at the CancerX event at JPMorgan in San Francisco

Having out with a good friend at the CancerX event at JPMorgan in San Francisco

#CancerX accelerates real-world cancer innovation to cut mortality in half by 2047

…so patients benefit sooner and the CancerX community can scale proven solutions into everyday care.

#JPM2026 #medsky #pinksocks

#NovoNordisk's new chief executive, #MikeDoustdar, has told the #JPM2026 Healthcare conference that the key to competing in the #GLP1 agonist category for #weightloss will be to make the most of cash-pay channels.

pharmaphorum.com/news/jpm-nov...

Happening TODAY at #JPM2026!

Don’t miss our CEO @benjaminloakes.bsky.social’s presentation at the J.P. Morgan Healthcare Conference (8:30 am PT) and panel on #biotech innovation at Fierce JPM Week (3:00 pm PT).

#JPM26 #CRISPR #GeneEditing #EpigeneticEditing #CVD

Innovation starts when we stop to listen.

Patients' experiences fuel our innovation, inspiring us to help people live happier, fuller lives.

🎥 Hear from the people who drive our purpose.

#AheadTogether #JPM2026 #JPM26